Literature DB >> 2728618

The role of RNA segment 1 in an in vitro host restriction occurring in an avian influenza virus mutant.

C Penn1.   

Abstract

A temperature sensitive mutant, ts C47, derived from A/FPV/Rostock/34 and with a ts mutation in RNA segment 8, fails to form plaques in MDCK cells. From data obtained with reassortant viruses using the human influenza isolate A/FM/1/47 it was apparent that more than one mutation contributed to the temperature-sensitive (ts) and host range (hr) phenotypes of ts C47, and the phenotype of reassortants containing RNA segment 1 from A/FM/1/47 indicated that this segment was involved. A single nucleotide substitution at nucleotide 1961, resulting in valine instead of methionine in the predicted amino acid sequence of polypeptide PB2, was found in RNA segment 1 of ts C47, but this mutation did not segregate with the attenuated phenotype on gene reassortment. The following conclusions are drawn: (a) that ts C47 has at least two mutations in addition to that already known to exist in RNA segment 8, one of which (that in RNA segment 1) does not contribute to the observed ts hr phenotypes and (b) that the hr phenotype can be suppressed by substitution of RNA segment 1 by that of another strain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2728618     DOI: 10.1016/0168-1702(89)90092-0

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

1.  Sequences in influenza A virus PB2 protein that determine productive infection for an avian influenza virus in mouse and human cell lines.

Authors:  Y Yao; L J Mingay; J W McCauley; W S Barclay
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Identification of human H1N2 and human-swine reassortant H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada (2003 to 2005).

Authors:  Alexander I Karasin; Suzanne Carman; Christopher W Olsen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.